TickerFacts.

Company research / UHS

Universal Health Services Inc (UHS)

Build a valuation ↗↓ Download CSV

SEC name UNIVERSAL HEALTH SERVICES INC · CIK 0000352915 · NYSE · Services-General Medical & Surgical Hospitals, NEC

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Universal Health Services Inc reported revenue of $17.36B. Revenue grew 9.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $18.11B.

Key ratios (year ended 2025-12-31)

11.5%
Operating margin
8.6%
Net margin
20.3%
Return on year-end equity
9.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-21

Headquarters locality: King of Prussia · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$18.11B$17.36B$15.83B$14.28B$13.40B$12.64B$11.56B$11.38B$10.77B$10.41B$9.77B
Operating Income$2.06B$1.99B$1.68B$1.18B$1.00B$1.36B$1.36B$1.22B$1.18B$1.28B$1.28B
Depreciation & Amortization$641.16M$618.74M$584.83M$568.04M$581.86M$533.21M$510.49M$490.39M$453.05M$447.76M$416.61M
EBITDA$2.70B$2.61B$2.27B$1.74B$1.59B$1.90B$1.87B$1.71B$1.63B$1.73B$1.70B
Net Income$1.53B$1.49B$1.14B$717.79M$675.61M$991.59M$943.95M$814.85M$779.71M$752.30M$702.41M
EPS (Diluted)n/a$23.10$16.82$10.23$9.14$11.82$10.99$9.13$8.31$7.81$7.14
Total Assets$15.94B$15.53B$14.47B$13.97B$13.49B$13.09B$13.48B$11.67B$11.27B$10.76B$10.32B
Long-Term Debt$4.90B$4.75B$4.50B$4.91B$4.81B$4.19B$3.86B$3.98B$4.00B$4.04B$4.14B
Shareholders' Equity$7.58B$7.34B$6.75B$6.20B$5.97B$6.19B$6.40B$5.58B$5.47B$5.05B$4.60B
Cash & Equivalents$138.80M$137.80M$125.98M$119.44M$102.82M$115.30M$1.22B$61.27M$105.22M$74.42M$33.75M
Operating Cash Flow$1.80B$1.86B$2.07B$1.27B$996.02M$883.70M$2.36B$1.44B$1.27B$1.25B$1.33B
Capital Expenditures$954.90M$1.02B$943.81M$743.05M$734.00M$855.66M$731.31M$634.10M$664.96M$557.51M$519.94M
Free Cash Flow$845.40M$849.25M$1.12B$524.74M$262.02M$28.04M$1.63B$804.37M$609.78M$690.08M$813.90M
Share Repurchases$1.07B$967.95M$670.75M$547.36M$832.92M$1.22B$206.72M$770.50M$397.43M$364.40M$353.38M
Dividends Paid$49.59M$51.27M$53.35M$55.48M$58.45M$65.90M$17.34M$53.00M$37.34M$38.21M$38.88M
Dividends Per Sharen/a$0.80$0.80$0.80$0.80$0.80n/a$0.60$0.40n/an/a
Weighted Average Diluted Sharesn/a64.46M67.90M70.12M73.83M83.69M85.59M89.04M93.75M96.33M98.38M
EPS (Basic)n/a$23.42$17.16$10.35$9.23$11.99$11.06$9.16$8.35$7.86$7.22

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView